Clinical Trials Browser

Phase 2 × Hematologic Neoplasms × Solutions × Clear all

NCT05952804 2026-01-30

IVIG for Infection Prevention After CAR-T-Cell Therapy

Phase 2 Recruiting

Other hematologic neoplasm

Hematologic Neoplasms